Intracranial Ewing sarcoma

被引:40
作者
Mazur, MA
Gururangan, S
Bridge, JA
Cummings, TJ
Mukundan, S
Fuchs, H
Larrier, N
Halperin, EC
机构
[1] Duke Univ, Brain Tumor Ctr, Ctr Med, Durham, NC 27710 USA
[2] Duke Univ, Ctr Med, Dept Pediat, Durham, NC 27710 USA
[3] Duke Univ, Ctr Med, Dept Pediat Hematol Oncol, Durham, NC 27710 USA
[4] Duke Univ, Ctr Med, Dept Pathol, Durham, NC 27710 USA
[5] Duke Univ, Ctr Med, Dept Neuroradiol, Durham, NC 27710 USA
[6] Duke Univ, Ctr Med, Dept Neurosurg, Durham, NC 27710 USA
[7] Duke Univ, Ctr Med, Dept Radiat Oncol, Durham, NC 27710 USA
[8] Univ Nebraska Med Ctr, Dept Pathol, Omaha, NE 68198 USA
[9] Univ Nebraska Med Ctr, Dept Pediat, Omaha, NE 68198 USA
[10] Univ Nebraska Med Ctr, Dept Orthoped Surg, Omaha, NE 68198 USA
关键词
brain tumors; cancer genetics; Ewing; FISH; pathology;
D O I
10.1002/pbc.20430
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The occurrence of primary extraosseous Ewing sarcoma (EES) of the central nervous system (CNS) has only rarely been reported in the literature. it is important to distinguish this entity from the more common central primitive neuroectodermal tumor (PNET) of brain, since the management of these tumors is different from that of EES. We present the clinical, radiologic, and pathologic features of two cases of EES occurring in the brain. The diagnosis was further confirmed by detection of a rearrangement of the FLI1 and/or EWS gene loci in tumors from both patients using fluorescent in situ hybridization (FISH). Although rare, the possibility of EES should be considered particularly when tumors that arise near the meningeal surface of the brain and have the pathologic appearance of a PNET. Demonstration of t(l 1;22)(q24;q12) by molecular analysis essentially confirms the diagnosis and enables the oncologist to choose appropriate therapy.
引用
收藏
页码:850 / 856
页数:7
相关论文
共 31 条
[1]   Intracranial Ewing sarcoma/'peripheral' primitive neuroectodermal tumor of dural origin with molecular genetic confirmation [J].
Antunes, NL ;
Lellouch-Tubiana, A ;
Kalifa, C ;
Delattre, O ;
Pierre-Kahn, A ;
Rosenblum, MK .
JOURNAL OF NEURO-ONCOLOGY, 2001, 51 (01) :51-56
[2]  
ASKIN FB, 1979, CANCER, V43, P2438, DOI 10.1002/1097-0142(197906)43:6<2438::AID-CNCR2820430640>3.0.CO
[3]  
2-9
[4]   Adamantinoma-like Ewing's sarcoma: Genomic confirmation, phenotypic drift [J].
Bridge, JA ;
Fidler, ME ;
Neff, JR ;
Degenhardt, J ;
Wang, M ;
Walker, C ;
Dorfman, HD ;
Baker, KS ;
Seemayer, TA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (02) :159-165
[5]   Ewing's sarcoma: diagnostic, and therapeutic implications of molecular abnormalities [J].
Burchill, SA .
JOURNAL OF CLINICAL PATHOLOGY, 2003, 56 (02) :96-102
[6]  
CONTESSO G, 1992, CANCER, V69, P1012, DOI 10.1002/1097-0142(19920215)69:4<1012::AID-CNCR2820690431>3.0.CO
[7]  
2-V
[8]   Prognostic factors in Ewing's tumor of bone:: Analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study group [J].
Cotterill, SJ ;
Ahrens, S ;
Paulussen, M ;
Jürgens, HF ;
Voûte, PA ;
Gadner, H ;
Craft, AW .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) :3108-3114
[9]   Molecular biology of the Ewing's sarcoma/primitive neuroectodermal tumor family [J].
de Alava, E ;
Gerald, WL .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (01) :204-213
[10]   Primary peripheral PNET/Ewing's sarcoma of the dura: a clinicopathologic entity distinct from central PNET [J].
Dedeurwaerdere, F ;
Giannini, C ;
Sciot, R ;
Rubin, BP ;
Perilongo, G ;
Borghi, L ;
Ballotta, ML ;
Cornips, E ;
Demunter, A ;
Maes, B ;
Tos, APD .
MODERN PATHOLOGY, 2002, 15 (06) :673-678